These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22941475)

  • 1. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
    Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
    FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
    Peukert S; Miller-Moslin K
    ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog pathway inhibitors: a patent review (2009--present).
    Hadden MK
    Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Hedgehog Antagonists for Cancer Therapy.
    Khatra H; Bose C; Sinha S
    Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold hopping approach to a new series of smoothened antagonists.
    Lu W; Geng D; Sun Z; Yang Z; Ma H; Zheng J; Zhang X
    Bioorg Med Chem Lett; 2014 May; 24(10):2300-4. PubMed ID: 24726807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
    Ruiz i Altaba A
    Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
    Queiroz KC; Spek CA; Peppelenbosch MP
    Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule modulators of the Sonic Hedgehog signaling pathway.
    Stanton BZ; Peng LF
    Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog inhibition as an anti-cancer strategy.
    Raju GP; Pham D
    Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Hedgehog pathway in lung cancer.
    Dimou A; Bamias A; Gogas H; Syrigos K
    Lung Cancer; 2019 Jul; 133():56-61. PubMed ID: 31200829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog inhibitors: a patent review (2013 - present).
    Xin M
    Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
    Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
    Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
    Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
    Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog Signaling: From Basic Biology to Cancer Therapy.
    Wu F; Zhang Y; Sun B; McMahon AP; Wang Y
    Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
    Katoh M
    Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation.
    Wang Y; Arvanites AC; Davidow L; Blanchard J; Lam K; Yoo JW; Coy S; Rubin LL; McMahon AP
    ACS Chem Biol; 2012 Jun; 7(6):1040-8. PubMed ID: 22554036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.